Verve Therapeutics Inc (VERV) Company Profile & Statistics

Verve Therapeutics Inc
VERV
(Nasdaq - US)
Open
7.17
-0.14 (-1.92%)
in:usd•As of: Apr 16, 2024 14:39 UTC -4
Open
7.18
High
7.25
Low
7.05

About Verve Therapeutics Inc

CEO

Sekar Kathiresan

Headquarters

201 brookline avenue, suite 601

boston, ma 02215, united states

Auditor

Ernst & Young LLP

Employees

255

Share Holders

N/A

Website

www.vervetx.com

Industry

biotechnology

Sector

health technology

Company Overview

Verve Therapeutics is a genetic medicines company pioneering a new approach to the care of cardiovascular disease, transforming treatment from chronic management to single-course gene editing medicines. The company's lead product candidate includes VERVE-101. Verve Therapeutics is based in CAMBRIDGE, Mass.

Verve Therapeutics Inc Statistics

Valuation Measures

Market Capitalization ²	599.56M
Enterprise Value	393.38M
Enterprise Value/EBITDA (ttm)	-1.70
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	1.04
Price to Sales (ttm)	54.05
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	100.00%
Operating Margin (ttm)	-1701.70%
Profit Margin (ttm)	-2172.28%
Return on Equity (ttm)	-39.33%
Return on Invested Capital (ttm)	-39.81%
Return on Assets (ttm)	-30.92%

Income Statement

Revenue (ttm)	11.76M
Revenue Per Share (ttm)	0.14
Gross Profit (ttm)	11.76M
EBITDA (ttm)³	-232.05M
Net Income Avi to Common (ttm)	-200.07M
Diluted EPS (ttm)	-3.12

Share Statistics

Beta (5Y Monthly)	1.70
52-Week Change	-54.59%
S&P500 52-Week Change	21.69%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	83.62M
Dividend Yield	0.00%
Float ⁴	65.72M
% Held by Insiders	21.40%
% Held by Institutions	97.11%

Balance Sheet

Total Cash (mrq)	623.95M
Total Cash Per Share (mrq)	7.46
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	17.24%
Quick Ratio (mrq)	17.24%
Book Value Per Share (mrq)	7.31

Cash Flow

Operating Cash Flow Per Share (ytd)	-2.33
Free Cash Flow (ytd)	-158.83M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Verve Therapeutics Inc

Trade With A Regulated Broker